Published on:

Metoclopramide to get FDA black box warning

The U.S. FDA announced today that the manufacturers of metoclopramide, a drug used to treat gastrointestinal disorders, must add a black box warning to its drug labels about the risk of long-term or high-dose use. Chronic use of the drug has been linked to personal injuries, such as tardive dyskinesia.

To read more about the new warning for the pharmaceutical.